Scott Sherrill-Mix1,2, Young Hwang1, Aoife M Roche1, Abigail Glascock1, Susan R Weiss1, Yize Li1, Leila Haddad3, Peter Deraska3, Caitlin Monahan3, Andrew Kromer3, Jevon Graham-Wooten2, Louis J Taylor1, Benjamin S Abella4, Arupa Ganguly3, Ronald G Collman2, Gregory D Van Duyne5, Frederic D Bushman6. 1. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 2. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 3. Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 4. Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. 5. Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. vanduyne@pennmedicine.upenn.edu. 6. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. bushman@pennmedicine.upenn.edu.
Abstract
BACKGROUND: Rapid spread of SARS-CoV-2 has led to a global pandemic, resulting in the need for rapid assays to allow diagnosis and prevention of transmission. Reverse transcription-polymerase chain reaction (RT-PCR) provides a gold standard assay for SARS-CoV-2 RNA, but instrument costs are high and supply chains are potentially fragile, motivating interest in additional assay methods. Reverse transcription and loop-mediated isothermal amplification (RT-LAMP) provides an alternative that uses orthogonal and often less expensive reagents without the need for thermocyclers. The presence of SARS-CoV-2 RNA is typically detected using dyes to report bulk amplification of DNA; however, a common artifact is nonspecific DNA amplification, which complicates detection. RESULTS: Here we describe the design and testing of molecular beacons, which allow sequence-specific detection of SARS-CoV-2 genomes with improved discrimination in simple reaction mixtures. To optimize beacons for RT-LAMP, multiple locked nucleic acid monomers were incorporated to elevate melting temperatures. We also show how beacons with different fluorescent labels can allow convenient multiplex detection of several amplicons in "single pot" reactions, including incorporation of a human RNA LAMP-BEAC assay to confirm sample integrity. Comparison of LAMP-BEAC and RT-qPCR on clinical saliva samples showed good concordance between assays. To facilitate implementation, we developed custom polymerases for LAMP-BEAC and inexpensive purification procedures, which also facilitates increasing sensitivity by increasing reaction volumes. CONCLUSIONS: LAMP-BEAC thus provides an affordable and simple SARS-CoV-2 RNA assay suitable for population screening; implementation of the assay has allowed robust screening of thousands of saliva samples per week.
BACKGROUND: Rapid spread of SARS-CoV-2 has led to a global pandemic, resulting in the need for rapid assays to allow diagnosis and prevention of transmission. Reverse transcription-polymerase chain reaction (RT-PCR) provides a gold standard assay for SARS-CoV-2 RNA, but instrument costs are high and supply chains are potentially fragile, motivating interest in additional assay methods. Reverse transcription and loop-mediated isothermal amplification (RT-LAMP) provides an alternative that uses orthogonal and often less expensive reagents without the need for thermocyclers. The presence of SARS-CoV-2 RNA is typically detected using dyes to report bulk amplification of DNA; however, a common artifact is nonspecific DNA amplification, which complicates detection. RESULTS: Here we describe the design and testing of molecular beacons, which allow sequence-specific detection of SARS-CoV-2 genomes with improved discrimination in simple reaction mixtures. To optimize beacons for RT-LAMP, multiple locked nucleic acid monomers were incorporated to elevate melting temperatures. We also show how beacons with different fluorescent labels can allow convenient multiplex detection of several amplicons in "single pot" reactions, including incorporation of a human RNA LAMP-BEAC assay to confirm sample integrity. Comparison of LAMP-BEAC and RT-qPCR on clinical saliva samples showed good concordance between assays. To facilitate implementation, we developed custom polymerases for LAMP-BEAC and inexpensive purification procedures, which also facilitates increasing sensitivity by increasing reaction volumes. CONCLUSIONS:LAMP-BEAC thus provides an affordable and simple SARS-CoV-2 RNA assay suitable for population screening; implementation of the assay has allowed robust screening of thousands of saliva samples per week.
Authors: Cameron S Ball; Yooli K Light; Chung-Yan Koh; Sarah S Wheeler; Lark L Coffey; Robert J Meagher Journal: Anal Chem Date: 2016-03-24 Impact factor: 6.986
Authors: Daniel Butler; Christopher Mozsary; Cem Meydan; Jonathan Foox; Joel Rosiene; Alon Shaiber; David Danko; Ebrahim Afshinnekoo; Matthew MacKay; Fritz J Sedlazeck; Nikolay A Ivanov; Maria Sierra; Diana Pohle; Michael Zietz; Undina Gisladottir; Vijendra Ramlall; Evan T Sholle; Edward J Schenck; Craig D Westover; Ciaran Hassan; Krista Ryon; Benjamin Young; Chandrima Bhattacharya; Dianna L Ng; Andrea C Granados; Yale A Santos; Venice Servellita; Scot Federman; Phyllis Ruggiero; Arkarachai Fungtammasan; Chen-Shan Chin; Nathaniel M Pearson; Bradley W Langhorst; Nathan A Tanner; Youngmi Kim; Jason W Reeves; Tyler D Hether; Sarah E Warren; Michael Bailey; Justyna Gawrys; Dmitry Meleshko; Dong Xu; Mara Couto-Rodriguez; Dorottya Nagy-Szakal; Joseph Barrows; Heather Wells; Niamh B O'Hara; Jeffrey A Rosenfeld; Ying Chen; Peter A D Steel; Amos J Shemesh; Jenny Xiang; Jean Thierry-Mieg; Danielle Thierry-Mieg; Angelika Iftner; Daniela Bezdan; Elizabeth Sanchez; Thomas R Campion; John Sipley; Lin Cong; Arryn Craney; Priya Velu; Ari M Melnick; Sagi Shapira; Iman Hajirasouliha; Alain Borczuk; Thomas Iftner; Mirella Salvatore; Massimo Loda; Lars F Westblade; Melissa Cushing; Shixiu Wu; Shawn Levy; Charles Chiu; Robert E Schwartz; Nicholas Tatonetti; Hanna Rennert; Marcin Imielinski; Christopher E Mason Journal: Nat Commun Date: 2021-03-12 Impact factor: 14.919
Authors: James P Broughton; Xianding Deng; Guixia Yu; Clare L Fasching; Venice Servellita; Jasmeet Singh; Xin Miao; Jessica A Streithorst; Andrea Granados; Alicia Sotomayor-Gonzalez; Kelsey Zorn; Allan Gopez; Elaine Hsu; Wei Gu; Steve Miller; Chao-Yang Pan; Hugo Guevara; Debra A Wadford; Janice S Chen; Charles Y Chiu Journal: Nat Biotechnol Date: 2020-04-16 Impact factor: 68.164
Authors: Marie J Y Reolo; Carlos S R Eleazar; Joseph P Sonio; Ryonne T Solon; Janika L B Villamor; Alexandra K Loedin; Keith J M Moore Journal: J Biomol Tech Date: 2021-09
Authors: Scott W Tighe; Andrew F Hayden; Marcy L Kuentzel; Korin M Eckstrom; Jonathan Foox; Daniel L Vellone; Kristiaan H Finstad; Pheobe K Laaguiby; Jessica J Hoffman; Sridar V Chittur Journal: J Biomol Tech Date: 2021-09
Authors: Keith J M Moore; Jeremy Cahill; Guy Aidelberg; Rachel Aronoff; Ali Bektaş; Daniela Bezdan; Daniel J Butler; Sridar V Chittur; Martin Codyre; Fernan Federici; Nathan A Tanner; Scott W Tighe; Randy True; Sarah B Ware; Anne L Wyllie; Evan E Afshin; Andres Bendesky; Connie B Chang; Richard Dela Rosa; Eran Elhaik; David Erickson; Andrew S Goldsborough; George Grills; Kathrin Hadasch; Andrew Hayden; Seong-Young Her; Julie A Karl; Chang Hee Kim; Alison J Kriegel; Thomas Kunstman; Zeph Landau; Kevin Land; Bradley W Langhorst; Ariel B Lindner; Benjamin E Mayer; Lee A McLaughlin; Matthew T McLaughlin; Jenny Molloy; Christopher Mozsary; Jerry L Nadler; Melinee D'Silva; David Ng; David H O'Connor; Jerry E Ongerth; Olayinka Osuolale; Ana Pinharanda; Dennis Plenker; Ravi Ranjan; Michael Rosbash; Assaf Rotem; Jacob Segarra; Stephan Schürer; Scott Sherrill-Mix; Helena Solo-Gabriele; Shaina To; Merly C Vogt; Albert D Yu; Christopher E Mason Journal: J Biomol Tech Date: 2021-09